{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:51:01Z","timestamp":1787320261306,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118355","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T09:52:28Z","timestamp":1753005148000},"page":"118355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Riboceine and N-acetylcysteine protect normal prostate cells from chemotherapy-induced oxidative stress while selectively modulating the cytotoxicity of methotrexate and docetaxel in prostate (PC-3) and breast cancer (MCF-7) cells"],"prefix":"10.1016","volume":"190","author":[{"given":"Trudy J.","family":"Philips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit Banga","family":"N\u2019guessan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Dotse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Kofi","family":"Abankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-7107","authenticated-orcid":false,"given":"Regina","family":"Appiah-Opong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib1","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.08.020409","article-title":"A Systematic review of associations between non-communicable diseases and socioeconomic status within low- and lower-middle-income countries","volume":"8","author":"Williams","year":"2018","journal-title":"J. Glob. Health"},{"issue":"119","key":"10.1016\/j.biopha.2025.118355_bib2","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"18","key":"10.1016\/j.biopha.2025.118355_bib4","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/cancers16183123","article-title":"Dual-action therapeutics: DNA alkylation and antimicrobial peptides for cancer therapy","volume":"16","author":"Andr\u00e9s","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"10","key":"10.1016\/j.biopha.2025.118355_bib6","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib7","first-page":"5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/cancers14030627","article-title":"Chemotherapy side-effects: not all DNA damage is equal","volume":"14","author":"van den Boogaard","year":"2022","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2025.118355_bib9","first-page":"3461","article-title":"Management of hepatotoxicity of chemotherapy and targeted agents","volume":"11","author":"Mudd","year":"2021","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.biopha.2025.118355_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118355_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112503","article-title":"Clinical implications of chemotherapeutic agent organ toxicity on perioperative care","volume":"146","author":"Zeien","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"284","key":"10.1016\/j.biopha.2025.118355_bib12","first-page":"124","article-title":"Reactive oxygen species - sources, functions, oxidative damage","volume":"48","author":"Jakubczyk","year":"2020","journal-title":"Pol. Merkur Lek."},{"issue":"10","key":"10.1016\/j.biopha.2025.118355_bib13","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.seminoncol.2021.05.002","article-title":"Implications of reactive oxygen species on cancer formation and its treatment","volume":"48","author":"Shah","year":"2021","journal-title":"Semin Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-024-02278-8","article-title":"Free radicals and their impact on health and antioxidant defenses: a review","volume":"11","author":"Chandimali","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2025.118355_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114606","article-title":"Cellular red-ox system in health and disease: the latest update","volume":"162","author":"Jena","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118355_bib17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118355_bib18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib19","article-title":"Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants","volume":"2013","author":"Poljsak","year":"2013","journal-title":"Oxid. Med Cell Longev."},{"issue":"8","key":"10.1016\/j.biopha.2025.118355_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118355_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Mol. Asp. Med"},{"issue":"11","key":"10.1016\/j.biopha.2025.118355_bib22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/antiox12111953","article-title":"The key role of GSH in keeping the redox balance in mammalian cells: mechanisms and significance of GSH in detoxification via formation of conjugates","volume":"12","author":"Georgiou-Siafis","year":"2023","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.biopha.2025.118355_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10101429","article-title":"Role of glutathione in cancer: from mechanisms to therapies","volume":"10","author":"Kennedy","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2025.118355_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/736837","article-title":"Glutathione homeostasis and functions: potential targets for medical interventions","volume":"2012","author":"Lushchak","year":"2012","journal-title":"J. Amino Acids"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib25","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Traverso","year":"2013","journal-title":"Oxid. Med Cell Longev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjsurg.2014.11.014","article-title":"D-Ribose-L-cysteine supplementation enhances wound healing in a rodent model","volume":"210","author":"Saltman","year":"2015","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","article-title":"The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress","volume":"2","author":"Kerksick","year":"2005","journal-title":"J. Int Soc. Sports Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2025.118355_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-acetylcysteine-a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.biopha.2025.118355_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2022.103872","article-title":"D-ribose L-cysteine attenuates manganese-induced cognitive and motor deficit, oxidative damage, and reactive microglia activation","volume":"93","author":"Akingbade","year":"2022","journal-title":"Environ. Toxicol. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118355_bib30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"44","key":"10.1016\/j.biopha.2025.118355_bib31","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.2174\/1381612825666190123112647","article-title":"The role of antioxidants in cancer, friends or foes?","volume":"1;24","author":"Poljsak","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.biopha.2025.118355_bib32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118355_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol. Asp. Med."},{"issue":"7","key":"10.1016\/j.biopha.2025.118355_bib34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.184901","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18632\/oncotarget.6220","article-title":"Prostate cancer stem cells: the role of androgen and estrogen receptors","volume":"7","author":"Di Zazzo","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.biopha.2025.118355_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr. Cancer Ther."},{"issue":"9","key":"10.1016\/j.biopha.2025.118355_bib37","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3390\/ijms21093100","article-title":"Redox homeostasis and metabolism in cancer: a complex mechanism and potential targeted therapeutics","volume":"21","author":"Ghoneum","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118355_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/832059","article-title":"Combination effects of docetaxel and doxorubicin in hormone-refractory prostate cancer cells","volume":"2012","author":"Tsakalozou","year":"2012","journal-title":"Biochem Res Int"},{"issue":"17","key":"10.1016\/j.biopha.2025.118355_bib39","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.3390\/ijms241713162","article-title":"Effect of antioxidant supplementation on NET formation induced by LPS in vitro; the roles of vitamins E and C, glutathione, and N-acetyl cysteine","volume":"24","author":"Mu\u00f1oz-S\u00e1nchez","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118355_bib40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/foods13050774","article-title":"The combined antioxidant effects of N-acetylcysteine, vitamin D3, and glutathione from the intestinal-neuronal in vitro model","volume":"13","author":"Mul\u00e8","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.biopha.2025.118355_bib41","doi-asserted-by":"crossref","unstructured":"Finnerty M.C., Leach I.I.I.F.E., Zakharia Y., Nepple K.G., Bartlett M.G., et al. Identification of blood lipid markers of docetaxel treatment in prostate cancer patients. Scientific reports 2024; 14(1): 22069, doi: 10.1038\/s41598-024-73074-8.","DOI":"10.1038\/s41598-024-73074-8"},{"issue":"17","key":"10.1016\/j.biopha.2025.118355_bib42","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1021\/jf801744r","article-title":"Protection of human Hepg2 cells against oxidative stress by cocoa phenolic extract","volume":"56","author":"Martin","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/np200247g","article-title":"Induction of apoptosis In HL-60 cells through the ros-mediated mitochondrial pathway by ramentaceone from Drosera aliciae","volume":"75","author":"Kawiak","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2025.118355_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/OTT.S486300","article-title":"Integrated network pharmacology, machine learning and experimental validation to identify the key targets and compounds of tiaoshengongjian for the treatment of breast cancer","volume":"18","author":"Ying","year":"2025","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260584","article-title":"Comparative analysis of protein-protein interaction networks in metastatic breast cancer","volume":"17","author":"Hozhabri","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118355_bib46","doi-asserted-by":"crossref","first-page":"2055900","DOI":"10.1155\/2022\/2055900","article-title":"Network pharmacology and molecular docking analysis on molecular targets and mechanisms of bushen hugu decoction in the treatment of malignant tumor bone metastases","volume":"2022","author":"Sang","year":"2022","journal-title":"Biomed. Res Int"},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24515","article-title":"Characterizations and molecular docking mechanism of the interactions between peptide FDGDF (phe-Asp-Gly-Asp-Phe) and SOD enzyme","volume":"10","author":"Wen-Tao","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-88038-9","article-title":"Sobczak \u0141, P\u0142azi\u0144ski W, S\u0142awi\u0144ska-Brych A, Mizerska-Kowalska M, et al. Design, synthesis, molecular docking and anticancer activity evaluation of methyl salicylate-based thiazoles as PTP1B inhibitors","volume":"15","author":"Ko\u0142odziej-Sobczak","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118355_bib49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.6026\/97320630016468","article-title":"Molecular docking analysis of Bcl-2 with phyto-compounds","volume":"16","author":"Kirubhanand","year":"2020","journal-title":"Bioinformation"},{"issue":"12","key":"10.1016\/j.biopha.2025.118355_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33103","article-title":"Exploring the therapeutic mechanism of curcumin in prostate cancer using network pharmacology and molecular docking","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"50","key":"10.1016\/j.biopha.2025.118355_bib51","doi-asserted-by":"crossref","first-page":"47107","DOI":"10.1074\/jbc.M104516200","article-title":"Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells: the role of intracellular oxidation","volume":"276","author":"Troyano","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1515\/ntrev-2022-0013","article-title":"Development of (-)-epigallocatechin-3-gallate-loaded folate receptor-targeted nanoparticles for prostate cancer treatment","volume":"11","author":"Alserihi","year":"2021","journal-title":"Nanotechnol. Rev."},{"issue":"38","key":"10.1016\/j.biopha.2025.118355_bib53","doi-asserted-by":"crossref","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells","volume":"7","author":"Ippolito","year":"2016","journal-title":"Oncotarget"},{"issue":"221","key":"10.1016\/j.biopha.2025.118355_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007653","article-title":"Antioxidants accelerate lung cancer progression in mice","volume":"6","author":"Sayin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118355_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/IJN.S94384","article-title":"Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia","volume":"11","author":"Stapf","year":"2016","journal-title":"Int J. Nanomed."},{"issue":"6","key":"10.1016\/j.biopha.2025.118355_bib56","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1535-7163.MCT-09-1103","article-title":"Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition","volume":"9","author":"Wiltshire","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3C","key":"10.1016\/j.biopha.2025.118355_bib57","first-page":"2367","article-title":"Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel","volume":"25","author":"Wang","year":"2005","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5155\/eurjchem.3.2.147-151.569","article-title":"Cytotoxic and antioxidant effects of grape seed oil on the treatment of leukemia with methotrexate","volume":"3","author":"Sahin","year":"2012","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.biopha.2025.118355_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fphar.2014.00267","article-title":"Glutathione depletion in survival and apoptotic pathways","volume":"5","author":"De Nicola","year":"2014","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0773-6","article-title":"Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress","volume":"15","author":"Moghadam","year":"2015","journal-title":"BMC Complement Alter. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s40200-022-01165-2","article-title":"Anacardium occidentale leaves extract and riboceine mitigate hyperglycemia through anti-oxidative effects and modulation of some selected genes associated with diabetes","volume":"22","author":"Ukwenya","year":"2022","journal-title":"J. Diabetes Metab. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist Updat"},{"issue":"11","key":"10.1016\/j.biopha.2025.118355_bib63","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/febs.14813","article-title":"Glutathione S-transferase omega 1 inhibition activates JNK-mediated apoptotic response in breast cancer stem cells","volume":"286","author":"Manupati","year":"2019","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.biopha.2025.118355_bib64","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom10101429","article-title":"Role of glutathione in cancer: from mechanisms to therapies","volume":"10","author":"Kennedy","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/0284186X.2020.1834143","article-title":"Patient-reported outcomes in postmenopausal breast cancer survivors-comparisons with normative data","volume":"60","author":"Nielsen","year":"2021","journal-title":"Acta Oncol. (Madr. )"},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib66","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/ijms19030907","article-title":"Amino acid transporters and glutamine metabolism in breast cancer","volume":"19","author":"Cha","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118355_bib67","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)Molecular Cell Research"},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118355_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118355_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-cancerbio-041916-065808","article-title":"The two faces of reactive oxygen species in cancer","volume":"1","author":"Reczek","year":"2017","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.biopha.2025.118355_bib71","first-page":"664","article-title":"Prostate cancer chemotherapy by intratumoral administration of docetaxel-mesoporous silica nanomedicines","author":"Rivero-Buceta","year":"2024","journal-title":"Int J. Pharm."},{"issue":"13","key":"10.1016\/j.biopha.2025.118355_bib72","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.3390\/cancers15133308","article-title":"Crosstalk between microtubule stabilizing agents and prostate cancer","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24670","article-title":"Metronomic chemotherapy and drug repurposing: a paradigm shift in oncology","volume":"10","author":"Jan","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib74","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-014-1657-1","article-title":"N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models","volume":"121","author":"Muldoon","year":"2015","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.biopha.2025.118355_bib75","doi-asserted-by":"crossref","first-page":"1282361","DOI":"10.3389\/fphar.2024.1282361","article-title":"Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib76","first-page":"7302419","article-title":"Network pharmacology and molecular docking analysis of the mechanism underlying Yikunyin\u2019s therapeutic effect on menopausal syndrome","volume":"2022","author":"Tan","year":"2022","journal-title":"J. Evid. Based Complement Alter. Med"},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118355_bib77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"issue":"18","key":"10.1016\/j.biopha.2025.118355_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179998","article-title":"BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity","volume":"134","author":"Westaby","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.biopha.2025.118355_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33103","article-title":"Exploring the therapeutic mechanism of curcumin in prostate cancer using network pharmacology and molecular docking","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib80","first-page":"279","article-title":"Activation of mitogen-activated protein kinase associated with prostate cancer progression","volume":"59","author":"Gioeli","year":"1999","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118355_bib81","article-title":"Tumor necrosis factor alpha signaling activity and NCCN risk, adverse pathology, and progression during active surveillance in prostate cancer","volume":"43","author":"Driscoll","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118355_bib82","article-title":"Modulation of inflammatory mediators underlies the antitumor effect of the combination of morusin and docetaxel on prostate cancer cells","volume":"43","author":"Fadil","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"9","key":"10.1016\/j.biopha.2025.118355_bib83","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1134\/S0006297920090011","article-title":"Epidermal growth factor receptor: key to selective intracellular delivery","volume":"85","author":"Rosenkranz","year":"2020","journal-title":"Biochemistry (Mosc)"},{"issue":"4-5","key":"10.1016\/j.biopha.2025.118355_bib84","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14728222.2023.2218613","article-title":"Targeting the EGFR signaling pathway in cancer therapy: what\u2019s new in 2023?","volume":"27","author":"Halder","year":"2023","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.biopha.2025.118355_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-03042-1","article-title":"Icariin-curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the warburg effect","volume":"23","author":"Xu","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib86","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12094-014-1206-6","article-title":"Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in du-145 human prostate cancer cells by modulating PI3K-AKT pathway","volume":"17","author":"Dirican","year":"2015","journal-title":"Clin. Transl. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118355_bib87","first-page":"3864","article-title":"Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells","volume":"19","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118355_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107534","article-title":"Targeted and cytotoxic inhibitors used in the treatment of breast cancer","volume":"210","author":"Roskoski","year":"2024","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.biopha.2025.118355_bib89","doi-asserted-by":"crossref","first-page":"726","DOI":"10.17344\/acsi.2016.2428","article-title":"Design, synthesis, in vitro antiproliferative activity, binding modeling of 1,2,4,-triazoles as new anti-breast cancer agents","volume":"63","author":"Genc","year":"2016","journal-title":"Acta Chim. Slov."},{"issue":"6","key":"10.1016\/j.biopha.2025.118355_bib90","first-page":"392","article-title":"The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge","volume":"31","author":"Czarnecka-Operacz","year":"2014","journal-title":"Post. Derm. Alergol."},{"issue":"15","key":"10.1016\/j.biopha.2025.118355_bib91","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.3390\/molecules25153510","article-title":"In silico study identified methotrexate analog as potential inhibitor of drug resistant human dihydrofolate reductase for cancer therapeutics","volume":"25","author":"Rana","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118355_bib92","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41416-022-02031-x","article-title":"Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes","volume":"128","author":"Bax","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118355_bib93","doi-asserted-by":"crossref","first-page":"7956493","DOI":"10.1155\/2020\/7956493","article-title":"Effect of cellgevity\u00ae supplement on selected rat liver cytochrome p450 enzyme activity and pharmacokinetic parameters of carbamazepine","volume":"2020","author":"Amponsah","year":"2020","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118355_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2025.13462","article-title":"N-Acetyl-L-cysteine protects rat lungs and RLE-6TN cells from cigarette smoke-induced oxidative stress","volume":"31","author":"Chen","year":"2025","journal-title":"Mol. Med Rep."},{"issue":"14","key":"10.1016\/j.biopha.2025.118355_bib95","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.3390\/jcm13144127","article-title":"Anti-inflammatory and anti-oxidant properties of N-acetylcysteine: a fresh perspective","volume":"13","author":"Santus","year":"2024","journal-title":"J. Clin. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118355_bib96","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/jbcpp-2020-0099","article-title":"An insight on safety, efficacy, and molecular docking study reports Of N-acetylcysteine and its compound formulations","volume":"33","author":"Rind","year":"2022","journal-title":"J. Basic Clin. Physiol. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:59:54Z","timestamp":1755737994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":96,"alternative-id":["S0753332225005499"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118355","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Riboceine and N-acetylcysteine protect normal prostate cells from chemotherapy-induced oxidative stress while selectively modulating the cytotoxicity of methotrexate and docetaxel in prostate (PC-3) and breast cancer (MCF-7) cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118355"}}